Cystic fibrosis in a low-incidence population: two major mutations in Finland
- PMID: 7509311
- DOI: 10.1007/BF00210603
Cystic fibrosis in a low-incidence population: two major mutations in Finland
Abstract
The incidence of cystic fibrosis (CF) in Finland, 1:25,000 newborn, is one of the lowest in Caucasian populations. The delta F508 mutation accounts for 18/40 (45%) of CF chromosomes in Finland. Other mutations were therefore sought among the remaining 55%. Twelve out of 40 chromosomes (30%) were found to carry 394delTT, whereas G542X and 3732delA were each detected in one chromosome. Eight mutations remained unidentified using a testing panel for 26 mutations. Mutation 394delTT was associated exclusively with haplotype 23-36-13. Five unknown mutations were associated with different haplotypes for microsatellite markers, whereas three shared the same haplotype. Most delta F508 mutations and all unidentified mutations originated from regions of old and dense settlement in the coastal regions, whereas 394delTT was geographically clustered and enriched in a rural location, consistent with a local founder effect. The remote location of Finland and her population history give a plausible explanation for the rarity of CF in Finland.
Similar articles
-
Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.Hum Genet. 1993 Oct 1;92(3):289-95. doi: 10.1007/BF00244474. Hum Genet. 1993. PMID: 7691712
-
Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers.Hum Mol Genet. 1993 Jul;2(7):1015-22. doi: 10.1093/hmg/2.7.1015. Hum Mol Genet. 1993. PMID: 7689896
-
394delTT: a Nordic cystic fibrosis mutation.Hum Genet. 1994 Feb;93(2):157-61. doi: 10.1007/BF00210602. Hum Genet. 1994. PMID: 7509310
-
[DNA analysis and gene diagnosis of cystic fibrosis].Rinsho Byori. 1991 Oct;39(10):1057-64. Rinsho Byori. 1991. PMID: 1722259 Review. Japanese.
-
Genetic and geographical variability in cystic fibrosis: evolutionary considerations.Ciba Found Symp. 1996;197:97-114; discussion 114-8. doi: 10.1002/9780470514887.ch6. Ciba Found Symp. 1996. PMID: 8827370 Review.
Cited by
-
Newborn Screening for CF across the Globe-Where Is It Worthwhile?Int J Neonatal Screen. 2020 Mar 4;6(1):18. doi: 10.3390/ijns6010018. eCollection 2020 Mar. Int J Neonatal Screen. 2020. PMID: 33073015 Free PMC article. Review.
-
Cystic fibrosis patient characteristics and healthcare resource utilization in Finland using linked registries.Heliyon. 2024 Jun 22;10(13):e33439. doi: 10.1016/j.heliyon.2024.e33439. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040318 Free PMC article.
-
Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.J Genet Couns. 2005 Feb;14(1):1-15. doi: 10.1007/s10897-005-1496-5. J Genet Couns. 2005. PMID: 15789152
-
Cystic Fibrosis Polymorphic Variants in a Russian Population.Pharmgenomics Pers Med. 2020 Dec 1;13:679-686. doi: 10.2147/PGPM.S278806. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 33623413 Free PMC article.
-
The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.Genes (Basel). 2020 May 26;11(6):589. doi: 10.3390/genes11060589. Genes (Basel). 2020. PMID: 32466381 Free PMC article. Review.